 Predictive Oncology Inc. NASDAQ:POAI has announced the appointment of Dr Matthew J Hawryluk to its board of directors in support of the companys strategic initiatives and commercialization efforts. With a PhD in cell biology and biochemistry from the University of Pittsburgh School of Medicine, an MBA from Carnegie Mellon Universitys Tepper School of Business and a BSc from the University of Notre Dame, Dr Hawryluk currently serves as the executive vice president and chief business officer of Gristone bio Inc, Predictive Oncology noted. 